Skip to main content

Advertisement

Table 2 Adjusted mean values (± SE) of variables on lipid and insulin resistance

From: Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome

Lipid profiles Control HS alone HS with MetSa P value (Between groups) P value (Linear trend)
   Total cholesterol, mmol/L   4.54 ± 0.06 4.92 ± 0.08** 4.88 ± 0.12 0.012 0.002
   LDL cholesterol, mmol/L   2.74 ± 0.06 3.09 ± 0.07** 3.00 ± 0.10* 0.001 0.019
   Triglyceride, mmol/L   1.11 ± 0.05 1.48 ± 0.07***†† 2.20 ± 1.00***†† < 0.001 < 0.001
   HDL cholesterol, mmol/L   1.34 ± 0.02 1.23 ± 0.03** 1.09 ± 0.04*** < 0.001 < 0.001
   Lipoprotein(a), mmol/L   0.71 ± 0.05 0.77 ± 0.09 0.67 ± 0.09 0.632 0.699
   Apo B, g/L   0.77 ± 0.02 0.88 ± 0.02** 0.91 ± 0.03** < 0.001 < 0.001
   Apo A-I, g/L   1.27 ± 0.03 1.23 ± 0.03 1.24 ± 0.05 0.623 0.537
Plsama total homocysteine (tHcy) and HOMA-IR       
   Plasma tHcy, μmol/L   6.9 ± 0.2 7.2 ± 0.3 7.2 ± 0.4 0.593 0.471
   Fasting insulin, μU/ml   5.3 ± 0.5 6.8 ± 0.6 7.2 ± 0.9 0.083 0.056
   HOMA-IR   1.3 ± 0.1 1.7 ± 0.2 1.9 ± 0.2* 0.030 0.014
  1. Adjusted for age, sex, alcohol drinking (≥20 g/d), and smoking. LDL, low-density lipoprotein; HDL, high-density lipoprotein; apo B, apolipoprotein B; apo A-I, apolipoprotein A-I; HOMA-IR; homeostasis model assessment for insulin resistance.
  2. *P < 0.05, ** P < 0.01, *** P < 0.001; compared with the control (Bonferroni adjustment for multiple comparisons).
  3. P < 0.05, †† P < 0.001; compared with the HS alone (Bonferroni adjustment for multiple comparisons).